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 Supplementary Figure 1. In-vivo expression of coiled-coil labelled BMCs. TEM analysis 
of E. coli BL21 * (DE3) cells expressing: (A) CC-Di-A-PduA-U (B) CC-Di-B-PduA-U (C) C-
PduA-U (D) CC-Di-A-Citrine-PduA-U (E) CC-Di-B-Citrine-PduA-U (F) C-Citrine-PduA-U. 
Scale bars show 0.2 µm. 
 
 
 
 
 
 
 Supplementary Figure 2. SDS-PAGE analysis of CC-Di-B labeled BMC purification in 
comparison to a molecular weight marker (M) (kDa). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris-HCl, pH 8, containing 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris-HCl, pH 8, containing 20 mM 
NaCl), lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation of 
resuspended pellet, lane 7 – pellet after centrifugation of resuspended pellet, lane 8 - 
supernatant after centrifugation, lane 9 pellet after centrifugation in 80 mM NaCl, 
resuspended in 20 mM Tris-HCl pH 8. Sample volumes of 2 µL were loaded in lanes 1 and 
2, whilst lanes 3 to 9 were loaded with 5 μL sample. 
 
 
 
 
 
 Supplementary Figure 3. SDS-PAGE analysis of CC-Di-B-Citrine labeled BMC 
purification in comparison to a molecular weight marker (M) (kDa). Lane 1 – lysate, 
lane 2 – supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM 
NaCl), lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation of 
resuspended pellet, lane 7 – pellet after centrifugation of resuspended pellet, lane 8 - 
supernatant after centrifugation, lane 9 pellet after centrifugation in 80 mM NaCl, 
resuspended in 20 mM Tris-HCl, pH 8. Sample volumes of 2 µL were loaded in lanes 1 and 
2, whilst lanes 3 to 9 were loaded with 5 μL sample. 
 
 
Supplementary Figure 4. Western Blot analysis of coiled-coil tagged BMCs in 
comparison to a molecular weight marker (M) (kDa). Samples were analyzed by SDS-
PAGE and subsequently western blotted with an anti-His primary antibody, designed to bind 
to the His-tag present on all of the PduA fusions. (A) Lysates from a 1 g wet cell pellet and 
(B) final BMC containing purified fractions in comparison to a molecular weight standard. 
 
 
 
 
 
 
 
 Supplementary Figure 5. SDS-PAGE analysis of CC-Di-A labeled BMC purification in 
comparison to a molecular weight marker (M) (kDa). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris-HCl, pH 8.0,  containing 20 mM 
NaCl), lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 mM Tris-
HCl pH 8. Sample volumes of 2 µL were loaded in lanes 1 and 2, whilst lanes 3 to 7 were 
loaded with 5 μL sample. 
 
 
 Supplementary Figure 6. SDS-PAGE analysis of C labeled BMC purification in 
comparison to a molecular weight marker (M) (kDa). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM 
NaCl), lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 mM Tris-
HCl pH 8. Sample volumes of 2 µL were loaded in lanes 1 and 2, whilst lanes 3 to 7 were 
loaded with 5 μL sample. 
 
 
 
 Supplementary Figure 7. SDS-PAGE analysis of CC-Di-A-Citrine labeled BMC 
purification in comparison to a molecular weight marker (M) (kDa). Lane 1 – lysate, 
lane 2 – supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM 
NaCl), lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 mM Tris-
HCl pH 8. Sample volumes of 2 µL were loaded in lanes 1 and 2, whilst lanes 3 to 7 were 
loaded with 5 μL sample. 
 
 
 Supplementary Figure 8. SDS-PAGE analysis of C-Citrine labeled BMC purification in 
comparison to a molecular weight marker (M) (kDa). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris-HCl, pH 8.0, containing 20 mM 
NaCl), lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 mM Tris-
HCl, pH 8. Sample volumes of 2 µL were loaded in lanes 1 and 2, whilst lanes 3 to 7 were 
loaded with 5 μL sample. 
 
 
 
 
 
 
 
 
 
 Supplementary Figure 9. TEM analysis of resin embedded, thin-sectioned, purified 
BMCs. BMCs extracted from E. coli BL21 * (DE3) cells expressing the following modified 
PduA proteins.  (A) CC-Di-A-PduA-U. (B) CC-Di-B-PduA-U. (C) C-PduA-U. (D) CC-Di-A-
Citrine-PduA-U. (E) CC-Di-B-Citrine-PduA-U. (F) C-Citrine-PduA-U. Scale bars show 0.2 
µm. 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Figure 10. Recombinant production of empty BMCs. TEM micrographs 
of in-vivo (A) and purified (B) empty Pdu BMCs formed from the shell proteins PduA, B, B’, 
J, K, N and U (PduA-U). Scale bar shows 0.2 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Figure 11. Expression of fluorescent coiled-coil labelled BMCs. 
Confocal analysis of E. coli BL21 * (DE3) cells expressing (A) CC-Di-A-Citrine-PduA-U (B) 
CC-Di-B-Citrine-PduA-U (C) C-Citrine-PduA-U. Scale bars show 2 µm. 
 
 
 
 
 
 Supplementary Figure 12. Expression of fluorescent coiled-coil labelled BMCs. Full 
frame confocal and TEM analysis of E. coli BL21 * (DE3) cells after 2 hours of induction 
expressing (A, B, C) CC-Di-A-Citrine-PduA-U (D, E, F) CC-Di-B-Citrine-PduA-U (G, H, I) C-
Citrine-PduA-U. Scale bars show 5 µm (A, B, D, E, G, H) and 0.5 µm (C, F, I). 
 
 Supplementary Figure 13. Minimal requirements for BMC formation. TEM analyses of 
resin embedded, thin sectioned, E. coli BL21 * (DE3) cells producing the shell proteins 
PduB, B’, J, K, N and U (PduB-U). Scale bars show 0.2 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Figure 14. Expression of coiled-coil tagged mCherry. Confocal analysis 
of E. coli BL21 * (DE3) cells expressing (A) CC-Di-A-mCherry (B) CC-Di-B-mCherry (C) C-
mCherry. Scale bars show 2 µm. 
 
 
 
 
 
 
 Supplementary Figure 15. Expression of coiled-coil tagged mCherry. Full frame 
confocal and TEM analysis of E. coli BL21 * (DE3) cells after 2 hours of induction expressing 
(A, B, C) CC-Di-A-mCherry (D, E, F) CC-Di-B-mCherry (G, H, I) C-mCherry. Scale bars 
show 5 µm (A, B, D, E, G, H) and 0.5 µm (C, F, I). 
 
 
 Supplementary Figure 16. Localization of fluorescent proteins to coiled-coil labelled 
BMCs. Full frame confocal and TEM analysis of E. coli BL21 * (DE3) cells after 2 hours of 
induction expressing CC-Di-B-Citrine-PduA-U with (A, B, C) CC-Di-A-mCherry (D, E, F) CC-
Di-B-mCherry (G, H, I) C-mCherry. Scale bars show 5 µm (A, B, D, E, G, H) and 0.5 µm (C, 
F, I). 
 
 
 
 Supplementary Figure 17. Expression of PduA variants in E. coli. TEM analyses of resin 
embedded, thin sectioned, E. coli BL21 * (DE3) cells producing (A – F) a permuted variant of 
PduA (PduAP) and (G) unpermuted PduA. A single sheet is highlighted in (B) with a white 
circle, whereas two parallel sheets are highlighted with a red circle in the same panel. Scale 
bars show 0.2 µm. 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Figure 18. Expression of circularly permuted BMCs. TEM analyses of 
resin embedded, thin sectioned, E. coli BL21 * (DE3) cells producing wild type PduA BMCs 
and circularly permuted PduAP BMCs. (A + C) PduA-U in-vivo and ‘isolated’ (B + D) PduAP-
U. Scale bars show 0.2 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Figure 19. Expression of fluorescent, coiled-coil labelled, circularly 
permuted BMCs. Confocal analysis of E. coli BL21 * (DE3) cells expressing (A) CC-Di-A-
Citrine-PduAP-U (B) CC-Di-B-Citrine-PduAP-U (C) C-Citrine-PduAP-U. Scale bars show 2 
µm. 
 
 
 
 
 
 
 
 Supplementary Figure 20. Expression of fluorescent, coiled-coil labelled, circularly 
permuted BMCs. Full frame confocal and TEM analysis of E. coli BL21 * (DE3) cells after 2 
hours of induction expressing (A, B, C) CC-Di-A-Citrine-PduAP-U (D, E, F) CC-Di-B-Citrine-
PduAP-U (G, H, I) C -Citrine-PduAP-U. Scale bars show 5 µm (A, B, D, E, G, H) and 0.5 µm 
(C, F, I). 
 
 
 
 
 
 
 
 
 
 
  
Supplementary Figure 21. In-vivo expression of circularly permuted, coiled-coil 
labelled BMCs. TEM analysis of E. coli BL21 * (DE3) cells expressing permuted PduA 
variants: (A) CC-Di-A-PduAP-U. (B) CC-Di-B-PduAP-U. (C) C-PduAP-U. (D) CC-Di-A-Citrine-
PduAP-U. (E) CC-Di-B-Citrine-PduAP-U. (F) C-Citrine-PduAP-U. Scale bars show 0.2 µm. 
 
 
 
 
 
 Supplementary Figure 22. TEM analysis of coiled-coil tagged circularly permuted 
BMCs. TEM analysis of resin embedded, thin-sectioned, permuted PduA BMCs tagged with 
coiled-peptides from lysed E. coli BL21 * (DE3) cells expressing the following modified PduA 
proteins. (A) CC-Di-A-PduAP-U. (B) CC-Di-B-PduAP-U. (C) C-PduAP-U. (D) CC-Di-A-Citrine-
PduAP-U. (E) CC-Di-B-Citrine-PduAP-U. (F) C-Citrine-PduAP-U. Scale bars show 0.2 µm. 
 
 
 
 
 
 Supplementary Figure 23. Localization of fluorescent proteins to circularly permuted 
coiled-coil labelled BMCs. Full frame confocal and TEM analysis of E. coli BL21 * (DE3) 
cells after 2 hours of induction expressing CC-Di-B-PduAP-U with (A, B, C) CC-Di-A-
mCherry (D, E, F) CC-Di-B-mCherry (G, H, I) C-mCherry. Scale bars show 5 µm (A, B, D, E, 
G, H) and 0.5 µm (C, F, I). 
 
 
 
 
 
Supplementary Table 1. Description of the fusion proteins constructed for this study. 
CC-Di-A / CC-Di-B – de novo designed coiled-coil peptides, C – Control lacking a coiled-coil 
peptide, (His)6 – hexahistidine tag, TCS – thrombin cleavage sequence, Citrine – improved 
variant of yellow fluorescent protein, PduA – native Citrobacter freundii PduA, PduAP – 
circularly permuted PduA, mCherry – red fluorescent protein variant. 
Protein Name Description 
CC-Di-A-PduA CC-Di-A-(His)6-TCS-PduA 
CC-Di-B-PduA CC-Di-B-(His)6-TCS-PduA 
C-PduA C-(His)6-TCS-PduA 
CC-Di-A-Citrine-PduA CC-Di-A-(His)6-TCS-Citrine-PduA 
CC-Di-B-Citrine-PduA CC-Di-B-(His)6-TCS-Citrine-PduA 
C-Citrine-PduA C-(His)6-TCS-Citrine-PduA 
CC-Di-A-PduAP CC-Di-A-(His)6-TCS-PduAP 
CC-Di-B-PduAP CC-Di-B-(His)6-TCS-PduAP 
C-PduAP C-(His)6-TCS-PduAP 
CC-Di-A-Citrine-PduAP 
CC-Di-A-(His)6-TCS-Citrine-PduAP 
CC-Di-B-Citrine-PduAP CC-Di-B-(His)6-TCS-Citrine-PduAP 
C-Citrine-PduAP C-(His)6-TCS-Citrine-PduAP 
CC-Di-A-mCherry CC-Di-A-(His)6-TCS-mCherry 
CC-Di-B-mCherry CC-Di-B-(His)6-TCS-mCherry 
C-mCherry 
C-(His)6-TCS-mCherry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 2.  Oligonucleotides used in this study. Restriction sites are 
underlined. 
Name Sequence 5’ – 3’ 
Citrine AseI_FW GACATTAATATGGTGAGCAAGGGCGAGGAGCTG  
Citrine_SpeI_NdeI_RV GACACTAGTAAACATATGCTTGTACAGCTCGTCCATGCCGAG 
Citrine_NdeI_FW CACCATATGGTGAGCAAGGGCGAGGAGC 
Citrine_SpeI_RV CACACTAGTTTACTTGTACAGCTCGTCC 
mCherry_NdeI_FW CAGCATATGGTGAGCAAGGGCGAGG 
mCherry_SpeI_RV GACACTAGTTTACTTGTACAGCTCGTCCATGC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 3. Strains used in this study. 
Strain Genotype Source 
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
mk+), relA1, supE44, Δ(lac-proAB), [F′, 
traD36, proAB, laqIqZΔM15] 
Promega 
BL21 * (DE3) F– ompT hsdSB (rB– mB–) gal dcm (DE3) Novagen 
 
 
